Bimodal distribution of polyunsaturated fatty acids in schizophrenia suggests two endophenotypes of the disorder

Biological Psychiatry

Volumn 70, Issue 1, 2011, Pages 97-105

  Bentsen, Håvard ^a,b   Solberg, Dag K ^a   Refsum, Helge ^a   Gran, Jon Michael ^c   Bøhmer, Thomas ^b   Torjesen, Peter A ^b   Halvorsen, Ola ^d   Lingjærde, Odd ^b  

^a DIAKONHJEMMET HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d AKERSHUS UNIVERSITY HOSPITAL   (Norway)

Author keywords

tocopherol; desaturases; elongases; fatty acids; oxidative stress; schizophrenia

Indexed keywords

ALPHA TOCOPHEROL; ARACHIDONIC ACID; CLOZAPINE; DESATURASE; DOCOSAHEXAENOIC ACID; ELONGASE; OLANZAPINE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; POLYUNSATURATED FATTY ACID; QUETIAPINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIMODAL DISTRIBUTION; CELLULAR DISTRIBUTION; CIGARETTE SMOKING; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIETARY INTAKE; ENDOPHENOTYPE; ERYTHROCYTE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SEX DIFFERENCE;

ACETYLTRANSFERASES; ADOLESCENT; ADULT; ALPHA-TOCOPHEROL; CASE-CONTROL STUDIES; COHORT STUDIES; ENDOPHENOTYPES; FATTY ACID DESATURASES; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SCHIZOPHRENIA;

EID: 79958797375     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2011.02.011     Document Type: Article

References (74)

1. D.F. Horrobin, A.I.M. Glen, and K. Vaddadi The membrane hypothesis of schizophrenia Schizophr Res 13 1994 195 207 (Pubitemid 24302649)
2. S.P. Mahadik, and J.K. Yao Phospholipids in schizophrenia J.A. Lieberman, T.S. Stroup, D.O. Perkins, Textbook of Schizophrenia 2006 American Psychiatric Publishing Washington, DC 117 135
3. K.Q. Do, J.H. Cabungcal, A. Frank, P. Steullet, and M. Cuenod Redox dysregulation, neurodevelopment, and schizophrenia Curr Opin Neurobiol 19 2009 220 230
4. A.I. Glen, E.M. Glen, D.F. Horrobin, K.S. Vaddadi, M. Spellman, and N. Morse-Fisher A red cell membrane abnormality in a subgroup of schizophrenic patients: Evidence for two diseases Schizophr Res 12 1994 53 61 (Pubitemid 24135495)
5. M. Peet, J. Laugharne, N. Rangarajan, D. Horrobin, and G. Reynolds Depleted red cell membrane essential fatty acids in drug-treated schizophrenic patients J Psychiatr Res 29 1995 227 232
6. H. Fox, B.M. Ross, D. Tocher, D. Horrobin, I. Glen, and D. St. Clair Degradation of specific polyunsaturated fatty acids in red blood cells stored at -20 degrees C proceeds faster in patients with schizophrenia when compared with healthy controls Prostaglandins Leukot Essent Fatty Acids 69 2003 291 297 (Pubitemid 37346661)
7. J.R. Hibbeln, K.K. Makino, C.E. Martin, F. Dickerson, J. Boronow, and W.S. Fenton Smoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorder Biol Psychiatry 53 2003 431 441 (Pubitemid 36263017)
8. D.C. Doehlert, M.S. McMullen, J.L. Jannink, S. Panigrahi, H. Gu, and N.R. Riveland Evaluation of Oat Kernel Size Uniformity Crop Sci 44 2004 1178 1186 (Pubitemid 39052376)
9. G. McLachlan, and D. Peel Finite Mixture Models 2000 John Wiley & Sons New York
10. Y. Yang, J. Fan, and S. May Bimodality of plasma glucose distributions in Whites: A bootstrap approach to testing mixture models J Data Sci 8 2010 483 493
11. R Development Core Team R: A Language and Environment for Statistical Computing 2008 R Foundation for Statistical Computing Vienna
12. R. Bender, and S. Lange Adjusting for multiple testingwhen and how? J Clin Epidemiol 54 2001 343 349
13. M.R. Fokkema, E.N. Smit, I.A. Martini, H.A. Woltil, E.R. Boersma, and F.A. Muskiet Assessment of essential fatty acid and omega3-fatty acid status by measurement of erythrocyte 20:3omega9 (Mead acid), 22:5omega6/20:4omega6 and 22:5omega6/22:6omega3 Prostaglandins Leukot Essent Fatty Acids 67 2002 345 356 (Pubitemid 35397374)
14. E. Warensjo, M. Ohrvall, and B. Vessby Fatty acid composition and estimated desaturase activities are associated with obesity and lifestyle variables in men and women Nutr Metab Cardiovasc Dis 16 2006 128 136 (Pubitemid 43384710)
15. J. Slagsvold, K. Thorstensen, M. Kvitland, D. Erixon, N. Knagenhjelm, and M. Mack Fatty acid desaturase expression in human leukocytes correlates with plasma phospholipid fatty acid status Scand J Clin Lab Invest 69 2009 496 504
16. E.T. Aasheim, D. Hofso, J. Hjelmesaeth, K.I. Birkeland, and T. Bohmer Vitamin status in morbidly obese patients: A cross-sectional study Am J Clin Nutr 87 2008 362 369 (Pubitemid 351226072)
17. J.A. Lieberman, F.P. Bymaster, H.Y. Meltzer, A.Y. Deutch, G.E. Duncan, and C.E. Marx Antipsychotic drugs: Comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection Pharmacol Rev 60 2008 358 403
18. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity Consensus development conference on antipsychotic drugs and obesity and diabetes Diabetes Care 27 2004 596 601
19. I.I. Kut'ko, V.M. Frolov, I.G. Pustovoi, G.S. Rachkauskas, and V.V. Pavlenko Antioxidants in the treatment of schizophrenia (the correction of lipid peroxidation processes) Zh Nevrol Psikhiatr Im S S Korsakova 96 1996 32 34
20. C.S. Gama, M. Salvador, A.C. Andreazza, M.I. Lobato, M. Berk, F. Kapczinski, and P.S. Belmonte-de-Abreu Elevated serum thiobarbituric acid reactive substances in clinically symptomatic schizophrenic males Neurosci Lett 433 2008 270 273
21. G. Block, M. Dietrich, E.P. Norkus, J.D. Morrow, M. Hudes, B. Caan, and L. Packer Factors associated with oxidative stress in human populations Am J Epidemiol 156 2002 274 285 (Pubitemid 34810481)
22. M.M. Khan, D.R. Evans, V. Gunna, R.E. Scheffer, V.V. Parikh, and S.P. Mahadik Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics Schizophr Res 58 2002 1 10 (Pubitemid 35287278)
23. S.A. Sands, K.J. Reid, S.L. Windsor, and W.S. Harris The impact of age, body mass index, and fish intake on the EPA and DHA content of human erythrocytes Lipids 40 2005 343 347 (Pubitemid 40770944)
24. R.D. Reddy, M.S. Keshavan, and J.K. Yao Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline Schizophr Bull 30 2004 901 911 (Pubitemid 40469524)
25. S. Kropp, V. Kern, K. Lange, D. Degner, G. Hajak, and J. Kornhuber Oxidative stress during treatment with first- and second-generation antipsychotics J Neuropsychiatry Clin Neurosci 17 2005 227 231 (Pubitemid 41350611)
26. O. Akyol, H. Herken, E. Uz, E. Fadillioglu, S. Unal, and S. Sogut The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients The possible role of oxidant/antioxidant imbalance Prog Neuropsychopharmacol Biol Psychiatry 26 2002 995 1005 (Pubitemid 35245568)
27. J.K. Yao, R. Reddy, and D.P. van Kammen Abnormal age-related changes of plasma antioxidant proteins in schizophrenia Psychiatry Res 97 2000 137 151 (Pubitemid 32126553)
28. M.H. Polymeropoulos, L. Licamele, S. Volpi, K. Mack, S.N. Mitkus, and E.D. Carstea Common effect of antipsychotics on the biosynthesis and regulation of fatty acids and cholesterol supports a key role of lipid homeostasis in schizophrenia Schizophr Res 108 2009 134 142
29. D.R. Evans, V.V. Parikh, M.M. Khan, C. Coussons, P.F. Buckley, and S.P. Mahadik Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment Prostaglandins Leukot Essent Fatty Acids 69 2003 393 399 (Pubitemid 37464048)
30. A. Pillai, V. Parikh, J. Terry, and S.P. Mahadik Long-term antipsychotic treatments and crossover studies in rats: Differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain J Psychiatr Res 41 2007 372 386 (Pubitemid 46201949)
31. L. Arab Biomarkers of fat and fatty acid intake J Nutr 133 2003 925S 932S (Pubitemid 36262800)
32. M.S. Manku, D.F. Horrobin, Y.S. Huang, and N. Morse Fatty acids in plasma and red cell membranes in normal humans Lipids 18 1983 906 908 (Pubitemid 14197032)
33. E.J. Giltay, L.J.G. Gooren, A.W.F.T. Toorians, M.B. Katan, and P.L. Zock Docosahexaenoic acid concentrations are higher in women than in men because of estrogenic effects Am J Clin Nutr 80 2004 1167 1174 (Pubitemid 41350675)
34. X.Y. Zhang, Y.L. Tan, L.Y. Cao, G.Y. Wu, Q. Xu, Y. Shen, and D.F. Zhou Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics Schizophr Res 81 2006 291 300 (Pubitemid 43107705)
35. P.K. Ranjekar, A. Hinge, M.V. Hegde, M. Ghate, A. Kale, and S. Sitasawad Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients Psychiatry Res 121 2003 109 122 (Pubitemid 37500981)
36. L.F. Andersen, K. Solvoll, L.R. Johansson, I. Salminen, A. Aro, and C.A. Drevon Evaluation of a food frequency questionnaire with weighed records, fatty acids, and alpha-tocopherol in adipose tissue and serum Am J Epidemiol 150 1999 75 87 (Pubitemid 29297272)
37. M. Saadatian-Elahi, N. Slimani, V. Chajes, M. Jenab, J. Goudable, and C. Biessy Plasma phospholipid fatty acid profiles and their association with food intakes: Results from a cross-sectional study within the European Prospective Investigation into Cancer and Nutrition Am J Clin Nutr 89 2009 331 346
38. L. Zhou, and A. Nilsson Sources of eicosanoid precursor fatty acid pools in tissues J Lipid Res 42 2001 1521 1542 (Pubitemid 33020085)
39. J.E. Mellor, J.D.E. Laugharne, and M. Peet Omega-3 fatty acid supplementation in schizophrenic patients Hum Psychopharmacol 11 1996 39 46 (Pubitemid 26068357)
40. J. Assies, R. Lieverse, P. Vreken, R.J. Wanders, P.M. Dingemans, and D.H. Linszen Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group Biol Psychiatry 49 2001 510 522 (Pubitemid 32226409)
41. M. Strassnig, J. Singh Brar, and R. Ganguli Dietary fatty acid and antioxidant intake in community-dwelling patients suffering from schizophrenia Schizophr Res 76 2005 343 351 (Pubitemid 40804781)
42. M. Arvindakshan, S. Sitasawad, V. Debsikdar, M. Ghate, D. Evans, and D.F. Horrobin Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients Biol Psychiatry 53 2003 56 64 (Pubitemid 36050936)
43. J.K. Yao, D.P. van Kammen, and J.A. Welker Red blood cell membrane dynamics in schizophrenia II. Fatty acid composition Schizophr Res 13 1994 217 226 (Pubitemid 24302651)
44. M.G. Traber Vitamin E regulatory mechanisms Annu Rev Nutr 27 2007 347 362 (Pubitemid 351373361)
45. C.J. Foy, A.P. Passmore, M.D. Vahidassr, I.S. Young, and J.T. Lawson Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease QJM 92 1999 39 45 (Pubitemid 29034099)
46. K.E. Charlton, T.L. Rabinowitz, L.N. Geffen, and M.A. Dhansay Lowered plasma vitamin C, but not vitamin E, concentrations in dementia patients J Nutr Health Aging 8 2004 99 107 (Pubitemid 38374596)
47. M.W. Clarke, J.R. Burnett, and K.D. Croft Vitamin E in human health and disease Crit Rev Clin Lab Sci 45 2008 417 450
48. E.T. Morgan Impact of infectious and inflammatory disease on cytochrome P450-mediated drug metabolism and pharmacokinetics Clin Pharmacol Ther 85 2009 434 438
49. G.L. Milne, H. Yin, and J.D. Morrow Human biochemistry of the isoprostane pathway J Biol Chem 283 2008 15533 15537
50. O. Berdeaux, O. Scruel, T. Durand, and J.L. Cracowski [Isoprostanes, biomarkers of lipid peroxidation in humans. Part 2: Quantification methods] Pathol Biol (Paris) 53 2005 356 363 (Pubitemid 40943321)
51. F. Michel, D. Bonnefont-Rousselot, E. Mas, J. Drai, and P. Therond [Biomarkers of lipid peroxidation: Analytical aspects] Ann Biol Clin (Paris) 66 2008 605 620
52. A. Dietrich-Muszalska, and B. Olas Isoprostenes as indicators of oxidative stress in schizophrenia World J Biol Psychiatry 10 2009 27 33
53. S. Basu, and J. Helmersson Factors regulating isoprostane formation in vivo Antioxid Redox Signal 7 2005 221 235 (Pubitemid 40187939)
54. M.C. Irizarry, Y. Yao, B.T. Hyman, J.H. Growdon, and D. Pratico Plasma F2A isoprostane levels in Alzheimer's and Parkinson's disease Neurodegener Dis 4 2007 403 405 (Pubitemid 47557280)
55. C. Feillet-Coudray, F. Chone, F. Michel, E. Rock, P. Thieblot, and Y. Rayssiguier Divergence in plasmatic and urinary isoprostane levels in type 2 diabetes Clin Chim Acta 324 2002 25 30 (Pubitemid 35245491)
56. S. Grignon, and J.M. Chianetta Assessment of malondialdehyde levels in schizophrenia: A meta-analysis and some methodological considerations Prog Neuropsychopharmacol Biol Psychiatry 31 2007 365 369 (Pubitemid 46209416)
57. A.O. Skinner, S.P. Mahadik, and D.L. Garver Thiobarbituric acid reactive substances in the cerebrospinal fluid in schizophrenia Schizophr Res 76 2005 83 87 (Pubitemid 40824563)
58. A. Yessoufou, N. Soulaimann, S.A. Merzouk, K. Moutairou, H. Ahissou, and J. Prost N-3 fatty acids modulate antioxidant status in diabetic rats and their macrosomic offspring Int J Obes (Lond) 30 2006 739 750
59. K. Arab, A. Rossary, F. Flourie, Y. Tourneur, and J.P. Steghens Docosahexaenoic acid enhances the antioxidant response of human fibroblasts by upregulating gamma-glutamyl-cysteinyl ligase and glutathione reductase Br J Nutr 95 2006 18 26 (Pubitemid 43250708)
60. D. Richard, K. Kefi, U. Barbe, P. Bausero, and F. Visioli Polyunsaturated fatty acids as antioxidants Pharmacol Res 57 2008 451 455
61. M.T. Nakamura, and T.Y. Nara Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases Annu Rev Nutr 24 2004 345 376
62. Y. Qin, K.T. Dalen, J.A. Gustafsson, and H.I. Nebb Regulation of hepatic fatty acid elongase 5 by LXRalpha-SREBP-1c Biochim Biophys Acta 1791 2009 140 147
63. G. Malerba, L. Schaeffer, L. Xumerle, N. Klopp, E. Trabetti, and M. Biscuola SNPs of the FADS gene cluster are associated with polyunsaturated fatty acids in a cohort of patients with cardiovascular disease Lipids 43 2008 289 299
64. P. Rzehak, J. Heinrich, N. Klopp, L. Schaeffer, S. Hoff, and G. Wolfram Evidence for an association between genetic variants of the fatty acid desaturase 1 fatty acid desaturase 2 (FADS1 FADS2) gene cluster and the fatty acid composition of erythrocyte membranes Br J Nutr 101 2009 20 26 (Pubitemid 352795577)
65. T. Tanaka, J. Shen, G.R. Abecasis, A. Kisialiou, J.M. Ordovas, and J.M. Guralnik Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI Study PLoS Genet 5 2009 e1000338
66. L. Xie, and S.M. Innis Genetic variants of the FADS1 FADS2 gene cluster are associated with altered (n-6) and (n-3) essential fatty acids in plasma and erythrocyte phospholipids in women during pregnancy and in breast milk during lactation J Nutr 138 2008 2222 2228
67. E. Lattka, T. Illig, J. Heinrich, and B. Koletzko Do FADS genotypes enhance our knowledge about fatty acid related phenotypes? Clin Nutr 21 2010 64 69
68. D.F. Horrobin, and Y.S. Huang Schizophrenia: The role of abnormal essential fatty acid and prostaglandin metabolism Med Hypotheses 10 1983 329 336 (Pubitemid 13133895)
69. S.P. Mahadik, N.S. Shendarkar, R.E. Scheffer, S. Mukherjee, and E.E. Correnti Utilization of precursor essential fatty acids in culture by skin fibroblasts from schizophrenic patients and normal controls Prostaglandins Leukot Essent Fatty Acids 55 1996 65 70 (Pubitemid 26321120)
70. Y. Liu, R. Jandacek, T. Rider, P. Tso, and R.K. McNamara Elevated delta-6 desaturase (FADS2) expression in the postmortem prefrontal cortex of schizophrenic patients: Relationship with fatty acid composition Schizophr Res 109 2009 113 120
71. A. Erkkila, V.D. de Mello, U. Riserus, and D.E. Laaksonen Dietary fatty acids and cardiovascular disease: An epidemiological approach Prog Lipid Res 47 2008 172 187
72. E. Warensjo, J. Sundstrom, B. Vessby, T. Cederholm, and U. Riserus Markers of dietary fat quality and fatty acid desaturation as predictors of total and cardiovascular mortality: A population-based prospective study Am J Clin Nutr 88 2008 203 209 (Pubitemid 351988700)
73. K. Murakami, S. Sasaki, Y. Takahashi, K. Uenishi, T. Watanabe, and T. Kohri Lower estimates of delta-5 desaturase and elongase activity are related to adverse profiles for several metabolic risk factors in young Japanese women Nutr Res 28 2008 816 824
74. T. Suzuki, A.V. Delgado-Escueta, M.E. Alonso, R. Morita, N. Okamura, and Y. Sugimoto Mutation analyses of genes on 6p12-p11 in patients with juvenile myoclonic epilepsy Neurosci Lett 405 2006 126 131 (Pubitemid 44142829)